Kier Group (LSE:KIE) has been appointed under a Pre-Construction Services Agreement for the H50 high containment building at the UK Health Security Campus in Harlow, part of a wider £3.52bn programme.

What was announced

Kier Group plc (LSE:KIE) (KIE) said on 26 October 2026 that it has been appointed under a Pre-Construction Services Agreement (PCSA) for the new H50 high containment building at the UK Health Security Campus in Harlow, Essex. The announcement, headed "Kier to deliver critical bioscience centre at UK Health Security Campus", describes H50 as a facility that will provide laboratories for Containment Level 3 and 4 pathogens, the highest levels of biological containment used for dangerous pathogens.

The building forms part of a wider £3.52bn programme in Harlow, funding for which was allocated in the 2025 Spending Review. The campus is intended to bring the UK Health Security Agency's specialist scientific facilities and its headquarters together on a single site, and Kier describes the programme as "central to UKHSA's long-term transformation".

Kier did not disclose a value for the PCSA or for the H50 building itself. Some automated summaries of the release have attached a figure of around £500m to the project, but that number in the announcement relates to a separate hospital contract, discussed below, and not to H50.

Timeline

The project is at an early stage. Under the timetable set out in the release, early works are expected to begin from 2028, with main construction expected to start in the fourth quarter of 2029. The UK Health Security Campus as a whole is due to be complete and in service by 2038.

A pre-construction services agreement typically covers design development, planning and cost work ahead of a main build contract. The announcement does not say whether, or on what terms, Kier would go on to deliver the main construction works, and it should not be assumed that the full build is secured on the basis of this release.

Management comment and track record

Spencer Baber, managing director for Kier Strategic Projects, said: "We're proud to continue our work with UKHSA on a programme that will play a vital role in protecting the country." He added that "H50 is a highly complex facility and, as a key delivery partner to Government," it is the type of project that suits Kier's breadth of experience and expertise, supporting world-class scientific facilities that strengthen the UK's future health security. The release contains no comment from UKHSA, and it does not set out details of Kier's earlier work with the agency.

Kier said it has delivered more than 200 healthcare projects and major investment programmes across the UK. Earlier in 2026 the group was also appointed to deliver the new Hinchingbrooke Hospital, a project of around £500m awarded under the NHS Hospital 2.0 Alliance Framework. The H50 appointment therefore adds a specialist scientific facility to a healthcare pipeline that already includes a major hospital scheme.

Why it matters

For a contractor whose business is heavily weighted towards public-sector and regulated infrastructure work, long-dated government programmes provide visibility over future activity. The Harlow campus is a multi-year, centrally funded scheme that runs to 2038, and an early role on one of its most technically demanding buildings positions Kier within that programme. However, because the PCSA value is undisclosed and main construction is not expected until late 2029, the near-term financial contribution cannot be assessed from the announcement.

What to watch next

Points to monitor include whether Kier is subsequently awarded the main construction contract for H50, any disclosure of contract values, progress on the campus programme towards early works from 2028, and whether Kier picks up further packages on the wider £3.52bn scheme. Updates on order book and healthcare work in Kier's next trading statement would also give more context on how this appointment fits into the group's pipeline.